HMGA1 and pancreatic adenocarcinoma: Using this model, we demonstrated that HMGA1 deficiency markedly reduced the invasive capacity of PANC-1 cells in vitro (Fig. 1O) and significantly impairs tumor growth in vivo in a xenograft mouse model of pancreatic adenocarcinoma (Fig. 1P, Q).